ENDECE is a biopharmaceutical company focused on developing new drug therapies for multiple sclerosis (MS), and osmotic demyelination syndrome (ODS)
http://www.endece.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
3.1 seconds
James Yarger
1001 W●●●●●●aks LN
Me●●on , WI, 53092
US
View this contact
James Yarger
1001 W●●●●●●aks LN
Me●●on , WI, 53092
US
View this contact
1&1 Internet Inc.
Hostmaster ONEANDONE
701 ●●●● Rd.
Ches●●●●rook , PA, 19087
US
View this contact
BUY YOUR DOMAIN
17
YEARS
11
MONTHS
10
DAYS
1 & 1 INTERNET AG
WHOIS : whois.schlund.info
REFERRED : http://1and1.com
PAGES IN
THIS WEBSITE
16
SSL
EXTERNAL LINKS
63
SITE IP
50.63.68.1
LOAD TIME
3.127 sec
SCORE
6.2
ENDECE - Treatment of demyelinating diseases including osmotic demyelination syndrom and MS | endece.com Reviews
https://endece.com
ENDECE is a biopharmaceutical company focused on developing new drug therapies for multiple sclerosis (MS), and osmotic demyelination syndrome (ODS)
endece.com
ENDECE Neural Presents Updated NDC-1308 Data at ECTRIMS/ACTRIMS Meeting | Endece
http://endece.com/endece-neural-to-present-updated-ndc-1308-data-at-ectrimsactrims-meeting
Management Team & Strategic Advisors. Fact Sheets & Newsletters. ENDECE Neural Presents Updated NDC-1308 Data at ECTRIMS/ACTRIMS Meeting. September 9, 2014. New Data Show In Vivo Induction of Remyelination in Animal Model of Multiple Sclerosis (MS). NDC-1308, a Gain of Function Estradiol Analog for Inducing Remyelination in Multiple Sclerosis Patients. Friday, September 12, 2014. Steven H. Nye, Ph.D. Hynes Convention Center, Hall C. Induces significant remyelination in both the cortical and hippocampal b...
Scientific Advisory Board | Endece
http://endece.com/about/scientific-advisory-board
Management Team & Strategic Advisors. Fact Sheets & Newsletters. We are a small company with big relationships. JEFFREY COHEN, M.D. Director of the Experimental Therapeutics Program and the Clinical Neuroimmunology Fellowship at the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic…. BRUCE TRAPP, PH.D. STEVE WEITMAN, M.D., PH.D. 1001 W. Glen Oaks Lane,. Mequon, WI 53092. Jeffrey Cohen, M.D. In addition to his large clinical practice devoted primarily to the care of patie...
About Endece Neural | Endece
http://endece.com/development/about-endece-neural
Management Team & Strategic Advisors. Fact Sheets & Newsletters. Our researchers have identified multiple pathways that are involved in repairing the myelin sheath. Our lead compound, NDC-1308, is a novel chemical entity designed to induce oligodendrocyte progenitor cells (OPCs) the precursors of oligodendrocytes to mature into oligodendrocytes, the cells that synthesize and maintain the myelin sheath. We discovered and own the intellectual property surrounding our compounds, and our management team.
Sitemap | Endece
http://endece.com/sitemap
Management Team & Strategic Advisors. Fact Sheets & Newsletters. NDC-1308 A MULTIPLE TARGET APPRAOCH FOR REMYELINATION. Management Team & Strategic Advisors. David W. Keiser. James Yarger, Ph. D. Steve H. Nye, Ph.D. Fact Sheets & Newsletters. ENDECE Receives Additional U.S. Patent Covering NDC-1308 for Inducing Remyelination. ENDECE Newsletter May 2016. ENDECE to Present Data on NDC-1308, a Small Molecule with Remyelinating Activity for Treatment of Secondary Progressive Multiple Sclerosis.
ENDECE Neural’s NDC-1308 Induces Remyelination in Pre-clinical Multiple Sclerosis (MS) Study | Endece
http://endece.com/endece-neurals-ndc-1308-induces-remyelination-pre-clinical-multiple-sclerosis-ms-study
Management Team & Strategic Advisors. Fact Sheets & Newsletters. ENDECE Neural’s NDC-1308 Induces Remyelination in Pre-clinical Multiple Sclerosis (MS) Study. November 18, 2014. All research to date indicates that NDC-1308 is ready to advance to IND-enabling and clinical studies, commented James G. Yarger, Ph.D., Chief Executive Officer of ENDECE Neural. The IND-enabling program has been designed to determine the safety and toxicity of NDC-1308 and appropriate starting doses for initiatin...ENDECE to Pre...
TOTAL PAGES IN THIS WEBSITE
16
Endece Oncology | Endece Oncology
http://endeceoncology.com/media-press
Developing drugs that regulate genes in signaling pathways involved in tumor cell replication and death. 1001 W. Glen Oaks Lane. Mequon, WI 53092. Dr James Yarger, Ph.D., CEO. Our data suggests that ENDECE Oncology's lead drug activates biological pathways that normally kill damaged cells but are evaded by tumor cells.". Designed and Managed by Gear Marketing LLC.
About Endece Oncology | Endece Oncology
http://endeceoncology.com/about-endece
Developing drugs that regulate genes in signaling pathways involved in tumor cell replication and death. The lead compounds for regulating gene transcription and controlling cell death were selected from the ENDECE proprietary library of compounds designed to control the activity of nuclear receptors and appear to be effective against cancers with low five year survival rates. The most advanced compound is in late pre-clinical studies. 1001 W. Glen Oaks Lane. Mequon, WI 53092.
Products | Endece Oncology
http://endeceoncology.com/products
Developing drugs that regulate genes in signaling pathways involved in tumor cell replication and death. ENDECE Oncology’s cancer compounds are dual-acting estrogen receptor-β agonists that down-regulate genes essential for chromosome replication. In addition, genes that specifically trigger DNA damage, cell cycle arrest and cell death are significantly up-regulated. Treatment of human tumor cell lines with the lead compound creates a significant hurdle for continued cell growth and proliferation.
| Endece Oncology
http://endeceoncology.com/home
Developing drugs that regulate genes in signaling pathways involved in tumor cell replication and death. Is focused on the development of compounds, designed by ENDECE, to down-regulate gene transcription involved in chromosome replication pathways while up-regulating gene transcription involved in cell death. The value of ENDECE Oncology’s compounds resides in their demonstrated activity towards regulating genes in multiple signaling pathways specific to controlling tumor cell growth. Mequon, WI 53092.
» Education The Clinical Trials Education Network of WI
http://wiclinicaltrials.com/education
Developing Cures, Creating Jobs. Click to Download PDF Document. Clinical Research Fast Facts. In 2010, Wisconsin was home to 1,311 active clinical trials. That’s nearly 9% of the 15,134 clinical trials in the United States. Wisconsin clinical research is concentrated on: Cancers(744) Rare Diseases (419) Respiratory Disorders (157) Cardiovascular Diseases (82) Diabetes (44) Mental and Behavioral Disorders (42) HIV/AIDS (8). Trials in Wisconsin; PhRMA. Click Here to Download (PDF). Hip hop music promotion.
Chris Hurst | Web Developer | Designer | Brit | Web Design
http://www.iamchrishurst.com/web-endece.html
Web Design, Re-Skinning, PHP, JS, Wordpress. While freelancing for 2M, I took on the project while it was 'half finished', and was a challenge. It was a re-skinned theme to begin with but ending up nearly half 'standard' theme and half custom. I completed this project while in the employment of Second Melody.
» Partners The Clinical Trials Education Network of WI
http://wiclinicaltrials.com/partners
Aurora is a private non-profit integrated health care system incorporating leading-edge research and evidence-based best practice into high-quality patient care. As Wisconsin’s largest health care system, with 15 medical centers and hospitals, 185 clinic sites and a team of 3,600 physicians, Aurora has hundreds of active industry and government sponsored clinical trials at any given time. BioForward is the member-driven state association that is the voice of Wisconsin’s bioscience industry. We advoca...
» Resources The Clinical Trials Education Network of WI
http://wiclinicaltrials.com/resources
ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world. The Center for Information and Study on Clinical Research Participation (CISCRP) is a first-of-its-kind nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media, and policy makers about clinical research and the role each party plays in the process. Click Here to Download (PDF). Hip hop music promotion.
» Media Clips The Clinical Trials Education Network of WI
http://wiclinicaltrials.com/media-clips
Study lauds value of clinical trials in Wisconsin. Wisconsin may not be home to any of the major pharmaceutical companies, but they are feeding the state’s economy in other ways, by funding clinical trials of promising drug compounds conducted here, according to a study released Wednesday. Study finds clinical trials pump big dollars into state. Drug industry gauges economic impact of R&D in state. Study analyzes impact of clinical trials in Wisconsin. Click Here to Download (PDF). Hip hop music promotion.
TOTAL LINKS TO THIS WEBSITE
63
www.endecasillabo.com
endecasillabosciolto.blogspot.com
endecasillabosciolto
Informazioni: creatività, attivismo e think tank. Martedì 16 dicembre 2014. Boomerang shopping: cose che ti accorgerai di volere per Natale. Cosa succede quando sei di fretta e cerchi di recuperare regali per Natale tra il disperato, l'ossessivo e n scadenze miste? Che mentre uno cerca trova un sacco di cose che vorrebbe. Dannatissimo shopping-boomerang! In particolare, Star Wars. Segue a ruota lo Space Invaders. Duo con uno spledido we come in peace. Ma il top, sono queste due cose di Evangelion. Ok, po...
Default Parallels Plesk Panel Page
Web Server's Default Page. This page is generated by Parallels Plesk Panel. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Parallels Plesk Panel. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms.
Endecca: Northwest Indiana Painting Contractors, Painting Services and Flooring, Lake & Porter County, Indiana
710 N Colonial Drive, Hobart, IN. Painting Contractors and Flooring Services. Serving Lake and Porter County in Northwest Indiana for more than 20 years. Endecca Painting and Flooring is eager to provide all of your house or commercial painting services. Endecca is Greek for eleven and that’s where our customers rate us on a scale of one to ten. For more than 20 years we’ve enjoyed repeat painting and flooring projects throughout Lake and Porter County, Indiana. Planning to do it yourself? We are dependa...
www.endeccapainting.com
This Web page parked FREE courtesy of VIA Web Development. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Call us any time day or night (480) 624-2500.
ENDECE - Treatment of demyelinating diseases including osmotic demyelination syndrom and MS
Management Team & Strategic Advisors. About Osmotic Demyelination Syndrome. Fact Sheets & Newsletters. NEW CONCEPTS IN DRUG DISCOVERY AND DEVELOPMENT. Stopping or Reversing Disease Progression. ENDECE was founded in 2006 and is located in Mequon, Wisconsin and San Francisco, California. ENDECE Opens San Francisco Office. February 13, 2017. ENDECE to Attend 2017 J.P. Morgan Healthcare Investor Conference. January 10, 2017. LEARN HOW ENDECE DISCOVERED NDC-1308. AND OSMOTIC DEMYELINATION SYNDROME. The focus...
Endece | Compounds Regulating BioSwitch® Pathways for the Treatment of Cancer
Endece - Regulating BioSwitch Pathways. ENDECE is a biopharmaceutical company discovering and developing proprietary compounds that can be used to modulate nuclear receptors for treating human disease. The Myelin Repair Foundation and ENDECE Neural Collaborate to Develop Myelin Regenerative Compounds for Multiple Sclerosis Treatment. Endece, LLC. announced the formation of Endece Neural, LLC. Previous experience taught me the hard way that one should not attempt to start a business, especially in science...
Endece
Management Team & Strategic Advisors. Fact Sheets & Newsletters. REPAIRING THE MYELIN SHEATH. Pursuing an Elusive Treatment. ENDECE, LLC is a privately held biopharmaceutical company focused on discovering and developing new drug therapies to stop or reverse disease progression by controlling key cellular pathways. These therapies exert their control over these pathways by targeting receptors within cell nuclei that regulate certain genes. November 18, 2014. September 9, 2014. New Data Show In Vivo Induc...
endeceoncology.com
NOTICE: This domain name expired on 2/14/2018 and is pending renewal or deletion. Welcome to: endeceoncology.com. This Web page is parked for FREE, courtesy of GoDaddy.com. Is this your domain? Would you like to buy this. THE domain at THE price. Visit GoDaddy.com for the best values on. Restrictions apply. See website for details.
ENDE
Twoja przeglądarka nie pozwala poprawnie wyświetlać tej strony. 1 Pobrać najnowszą wersje Internet Explorera. 2 Zainstalować Google Chrome. 3 W miedzy czasie odwiedź nasz sklep na Etsy. Your browser doesn't allow for proper display of this website. What you can do? 1 Download newest version of Internet Explorer. 2 Install Google Chrome. 3 In the meantime you can visit our Etsy shop.
フリーランスエンジニア/デザイナーの為のお役立ちコンテンツとテック情報をお届けする【エンデック】
